For: | Santopaolo F, Lenci I, Milana M, Manzia TM, Baiocchi L. Liver transplantation for hepatocellular carcinoma: Where do we stand? World J Gastroenterol 2019; 25(21): 2591-2602 [PMID: 31210712 DOI: 10.3748/wjg.v25.i21.2591] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v25/i21/2591.htm |
Number | Citing Articles |
1 |
Tommy Ivanics, Chaya Shwaartz, Marco P. A. W. Claasen, Madhukar S. Patel, Peter Yoon, Nathanael Raschzok, David Wallace, Hala Muaddi, Carla Fiorella Murillo Perez, Bettina E. Hansen, Nazia Selzner, Gonzalo Sapisochin. Trends in indications and outcomes of liver transplantation in Canada: A multicenter retrospective study. Transplant International 2021; 34(8): 1444 doi: 10.1111/tri.13903
|
2 |
Jia-Jia He, Lei Shang, Qun-Wei Yu, Ning Jiao, Shuang Qiu, Wei-Xiong Zhu, Dong-Feng Wu, Yun-Er Tian, Qing Zhang. High expression of protein phosphatase 2 regulatory subunit B'' alpha predicts poor outcome in hepatocellular carcinoma patients after liver transplantation. World Journal of Gastrointestinal Oncology 2021; 13(7): 541 doi: 10.4251/wjgo.v13.i7.541
|
3 |
Tommaso Maria Manzia, Roberta Angelico, Carlo Gazia, Ilaria Lenci, Martina Milana, Oludamilola T Ademoyero, Domiziana Pedini, Luca Toti, Marco Spada, Giuseppe Tisone, Leonardo Baiocchi. <i>De novo</i> malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature. World Journal of Gastroenterology 2019; 25(35): 5356-5375 doi: 10.3748/wjg.v25.i35.5356
|
4 |
Mohamed Hassin Mohamed Chairi, Mónica Mogollón González, Alejandro José Pérez Alonso, Mireia Domínguez Bastante, María De Los Ángles Herrero Torres, Carmen Acosta Gallardo, Antonio Palomeque Jiménez. Liver Transplantation in Patients With Hepatocellular Carcinoma: Long-Term Survival Results. Transplantation Proceedings 2022; 54(1): 48 doi: 10.1016/j.transproceed.2021.09.065
|
5 |
Hua Liu, Jing Cheng, Heng Xu, Zhenzhen Wan. Lidocaine has antitumor effect on hepatocellular carcinoma via the circ_DYNC1H1/miR-520a-3p/USP14 axis. Open Life Sciences 2021; 16(1): 766 doi: 10.1515/biol-2021-0072
|
6 |
Preston Kim, Michael Littau, Talia B. Baker, Zaid Abdelsattar, Celsa Tonelli, Corinne Bunn, Sujay Kulshrestha, Fred A. Luchette, Marshall S. Baker. Intrahepatic cholangiocarcinoma: Is there a role for liver transplantation?. Surgery 2022; 171(3): 741 doi: 10.1016/j.surg.2021.09.034
|
7 |
Piter J. Bosma, Marius Wits, Ronald P. J. Oude-Elferink. Gene Therapy for Progressive Familial Intrahepatic Cholestasis: Current Progress and Future Prospects. International Journal of Molecular Sciences 2020; 22(1): 273 doi: 10.3390/ijms22010273
|
8 |
Magdelyn Mei-Theng Wong, Hui-Yin Chan, Norazlin Abdul Aziz, Thamil Selvee Ramasamy, Jan-Jin Bong, Ewe Seng Ch’ng, Subasri Armon, Suat-Cheng Peh, Sin-Yeang Teow. Interplay of autophagy and cancer stem cells in hepatocellular carcinoma. Molecular Biology Reports 2021; 48(4): 3695 doi: 10.1007/s11033-021-06334-9
|
9 |
Jun-cheng Guo, Yi-jun Yang, Min Guo, Jian-quan Zhang, Jin-fang Zheng, Zhuo Liu. Involvement of CDK11B-mediated SPDEF ubiquitination and SPDEF-mediated microRNA-448 activation in the oncogenicity and self-renewal of hepatocellular carcinoma stem cells. Cancer Gene Therapy 2021; 28(10-11): 1136 doi: 10.1038/s41417-020-00261-w
|
10 |
Dobrochna Dolicka, Michelangelo Foti, Cyril Sobolewski. The Emerging Role of Stress Granules in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(17): 9428 doi: 10.3390/ijms22179428
|
11 |
Julie K. Heimbach. Evolution of Liver Transplant Selection Criteria and U.S. Allocation Policy for Patients with Hepatocellular Carcinoma. Seminars in Liver Disease 2020; 40(04): 358 doi: 10.1055/s-0040-1709492
|
12 |
Darren J. H. Tan, Chloe Wong, Cheng Han Ng, Chen Wei Poh, Sneha Rajiv Jain, Daniel Q. Huang, Mark D. Muthiah. A Meta-Analysis on the Rate of Hepatocellular Carcinoma Recurrence after Liver Transplant and Associations to Etiology, Alpha-Fetoprotein, Income and Ethnicity. Journal of Clinical Medicine 2021; 10(2): 238 doi: 10.3390/jcm10020238
|
13 |
Li Liu, Xianxian Liang, Xiangxian Xu, Xiang Zhang, Jun Wen, Kun Chen, Xiaodan Su, Zhaogang Teng, Guangming Lu, Jian Xu. Magnetic mesoporous embolic microspheres in transcatheter arterial chemoembolization for liver cancer. Acta Biomaterialia 2021; 130: 374 doi: 10.1016/j.actbio.2021.05.031
|
14 |
Kelly Casler, Amanda Chaney. Cirrhosis. Nursing 2021; 51(2): 24 doi: 10.1097/01.NURSE.0000731828.24893.bb
|
15 |
Junfeng Ye, Yu Fu, Zhongfeng Wang, Jinhai Yu. Long non-coding RNA FOXP4-AS1 facilitates the biological functions of hepatocellular carcinoma cells via downregulating ZC3H12D by mediating H3K27me3 through recruitment of EZH2. Cell Biology and Toxicology 2021; doi: 10.1007/s10565-021-09642-9
|
16 |
Alexander Villalobos, William Wagstaff, Mian Guo, James Zhang, Zachary Bercu, Morgan J. Whitmore, Mircea M Cristescu, Bill S. Majdalany, Joel Wedd, Mehmet Akce, Joseph Magliocca, Marty T. Sellers, Nima Kokabi, Alessandro Granito. Predictors of Successful Yttrium-90 Radioembolization Bridging or Downstaging in Patients with Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/9926704
|
17 |
Veysel Ersan, Bora Barut, Sezai Yilmaz. The Timing of Liver Transplantation Following Downstaging: Wait of Not to Wait?. Journal of Gastrointestinal Cancer 2020; 51(4): 1152 doi: 10.1007/s12029-020-00491-z
|
18 |
Maria C. van Hooff, Milan J. Sonneveld, Jan N. Ijzermans, Michail Doukas, Dave Sprengers, Herold J. Metselaar, Caroline M. den Hoed, Robert A. de Man. External Validation of the RETREAT Score for Prediction of Hepatocellular Carcinoma Recurrence after Liver Transplantation. Cancers 2022; 14(3): 630 doi: 10.3390/cancers14030630
|
19 |
Zhe Yang, Shuo Wang, Xin-Yao Tian, Qin-Fen Xie, Li Zhuang, Qi-Yong Li, Cheng-Ze Chen, Shu-Sen Zheng. Impact of treatment modalities on patients with recurrent hepatocellular carcinoma after liver transplantation: Preliminary experience. Hepatobiliary & Pancreatic Diseases International 2020; 19(4): 365 doi: 10.1016/j.hbpd.2020.06.002
|
20 |
Amirhossein Azhie, Robert C Grant, Michael Herman, Lisa Wang, Jennifer J Knox, Mamatha Bhat. Phase II clinical trial of cabozantinib for the treatment of recurrent hepatocellular carcinoma after liver transplantation. Future Oncology 2022; 18(18): 2173 doi: 10.2217/fon-2021-1635
|
21 |
Vladimir J Lozanovski, Ali Ramouz, Ehsan Aminizadeh, Sadeq Ali-Hasan Al-Saegh, Elias Khajeh, Heike Probst, Susanne Picardi, Christian Rupp, De-Hua Chang, Pascal Probst, Arianeb Mehrabi. Prognostic role of selection criteria for liver transplantation in patients with hepatocellular carcinoma: a network meta-analysis. BJS Open 2022; 6(1) doi: 10.1093/bjsopen/zrab130
|
22 |
Shan Zhang, Zhong-Wei Chen, Shi-Min Meng, Qing-Lin Ding, Zhi-Biao Zhong, Yan-Hong Wei, Qi-Fa Ye, Kang-Hong Hu. Eukaryotic initiation factor 3e subunit is positively associated with tumorigenesis and development of hepatocellular carcinoma. World Chinese Journal of Digestology 2020; 28(12): 475 doi: 10.11569/wcjd.v28.i12.475
|
23 |
Mingxin Cui, Fengzhi Qu, Libing Wang, Xiaogang Liu, Jingkun Yu, Zhaoyuan Tang, Daming Cheng. m5C RNA methyltransferase-related gene NSUN4 stimulates malignant progression of hepatocellular carcinoma and can be a prognostic marker. Cancer Biomarkers 2022; 33(3): 389 doi: 10.3233/CBM-210154
|
24 |
Yi Duan, Yuanyuan Meng, Zhifeng Gao, Xiaoyu Wang, Huan Zhang. microRNA-9-5p protects liver sinusoidal endothelial cell against oxygen glucose deprivation/reperfusion injury. Open Life Sciences 2021; 16(1): 375 doi: 10.1515/biol-2021-0042
|
25 |
Gerardo Sarno, Roberto Montalti, Mariano Cesare Giglio, Gianluca Rompianesi, Federico Tomassini, Emidio Scarpellini, Giuseppe De Simone, Giovanni Domenico De Palma, Roberto Ivan Troisi. Hepatocellular carcinoma in patients with chronic renal disease: Challenges of interventional treatment. Surgical Oncology 2021; 36: 42 doi: 10.1016/j.suronc.2020.11.007
|
26 |
Patricia Holanda Almeida, Celso E L Matielo, Lilian A Curvelo, Rodrigo A Rocco, Guilherme Felga, Bianca Della Guardia, Yuri L Boteon. Update on the management and treatment of viral hepatitis. World Journal of Gastroenterology 2021; 27(23): 3249-3261 doi: 10.3748/wjg.v27.i23.3249
|
27 |
Jia-Jia He, Lei Shang, Qun-Wei Yu, Ning Jiao, Shuang Qiu, Wei-Xiong Zhu, Dong-Feng Wu, Yun-Er Tian, Qing Zhang. High expression of protein phosphatase 2 regulatory subunit B'' alpha predicts poor outcome in hepatocellular carcinoma patients after liver transplantation. World Journal of Gastrointestinal Oncology 2021; 13(7): 716-731 doi: 10.4251/wjgo.v13.i7.716
Abstract(154) |
Core Tip(162) |
Full Article(HTML)(715)
|
Full Article (PDF)-3081K(141)
|
Full Article (Word)-1169K(46)
|
Audio-587K(3)
|
Peer-Review Report-225K(39)
|
Answering Reviewers-274K(48)
|
Times Cited (0)
|
Total Visits (2685)
|
Open
|